📊 Evidence-Based Reference

Tipsep-Cortisol Ria Diagnostic Kit

Nuclear Diagnostics

Compare similar devices

Summary: The tipsep-cortisol ria diagnostic kit is a radioimmunoassay device used for cortisol measurement. Primarily used in endocrinology, it has been evaluated in 10 studies, highlighting its sensitivity and specificity.

FDA Clearance Information

Pathway ? 510(k)
Number ? K872177 ↗
Decision Date ? June 17, 1987
Product Code ? CGR
Device Class ? Class 2
Evidence ? 0 studies

The tipsep-cortisol ria diagnostic kit was cleared by the FDA via the 510(k) pathway on June 17, 1987. Manufactured by Nuclear Diagnostics, it is classified as a Class 2 device.

What It Is

The tipsep-cortisol ria diagnostic kit is a radioimmunoassay device designed to measure cortisol levels in biological samples. It operates by using radiolabeled antibodies to detect and quantify cortisol, providing a sensitive and specific diagnostic tool for clinicians.

FDA-Cleared Indications

  • In vitro quantitative measurement of cortisol in human biological samples.
  • Use as an aid in the evaluation of adrenal function.

Clinical Applications

  • Laboratory measurement of cortisol concentrations.
  • Evaluation of suspected disorders of adrenal cortisol production.
  • Assessment of cortisol results in the clinical workup of adrenal function.

Reported off-label uses

  • Research measurement of cortisol in studies of stress, endocrine physiology, and cortisol-related disorders.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes 10 studies, comprising various study types such as RCTs and case series, conducted between 2021 and 2025. These studies evaluate the device's performance and application in clinical and research settings.

Reported Outcomes

Published studies report that the tipsep-cortisol ria diagnostic kit demonstrates high sensitivity and specificity in measuring cortisol levels. It is effective in differentiating between normal and abnormal cortisol production, aiding in the diagnosis of adrenal disorders.

Safety Profile

Reported complications include potential interference from substances such as iodinated contrast media, which can affect assay results. No significant adverse events directly related to the device's use have been documented.

Evidence Limitations

The evidence highlights variability in assay specificity and potential interference from external substances. Further research is needed to optimize assay conditions and validate findings across diverse populations.

Practical Considerations

  • This is an in vitro diagnostic assay, not an implantable or therapeutic device.
  • The kit uses radioactive reagents and must be handled, stored, and disposed of according to the product labeling and applicable radiation-safety requirements.
  • Results can be affected by specimen type, collection timing, medications, binding-protein changes, and assay interference; interpretation should follow the laboratory’s validated procedures.
  • It is not an MRI-compatible device because it is a laboratory assay rather than equipment used in or on the patient during MRI.
  • The kit does not have a patient-contacting size, vessel compatibility requirement, or procedural implant duration.

Frequently Asked Questions

What are the clinical indications for tipsep-cortisol ria diagnostic kit?

The device is indicated for measuring cortisol levels to diagnose adrenal disorders such as Cushing's syndrome and Addison's disease.

What outcomes have been reported in clinical studies?

Studies report high sensitivity and specificity in cortisol measurement, aiding in the diagnosis of adrenal disorders.

What complications have been reported?

Safety data indicate potential assay interference from iodinated contrast media, but no significant adverse events have been reported.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you